XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.3
ORGANIZATION AND NATURE OF THE BUSINESS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 06, 2023
Jun. 15, 2023
Apr. 24, 2023
Mar. 17, 2023
Feb. 28, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 19, 2018
VAT net receivable and payable balance           $ 456,788   $ 456,788   $ 79,373  
Allowance for doubtful accounts           7,735,425   7,735,425   6,987,301  
Depreciation expense           124,910 $ 83,214 237,479 $ 248,670    
Accounts receivable, net                   322,010  
Amortization expense           88,168 $ 36,982 138,438 $ 53,389    
Goodwill           49,697   49,697   $ 49,697 $ 49,697
Deferred revenue           317,129   317,129      
Building Acquision [Member]                      
Cash $ 3,950,000   $ 1,054,872                
Equity method investment aggregate cost $ 2,000,020         0   0      
ICC International Cannabis Corp [Member]                      
Equity method investment aggregate cost           0   $ 0      
Equity method investment shares acquired, shares               3,000,000      
Closing price               $ 0      
National Bank of Greece [Member]                      
Equity method investment aggregate cost           9,419   $ 9,419      
Equity method investment shares acquired, shares               16,666      
Closing price               $ 0.53      
Pancreta Bank [Member]                      
Equity method investment aggregate cost           $ 8,113   $ 8,113      
Pharmaceuticals And Nutraceuticals Products License [Member]                      
Estimated useful life               5 years      
Greece [Member]                      
Cash   $ 109,330                  
Intangible assets   425,411                  
Income tax rate               22.00%      
Issuable stock amount   $ 316,081                  
Shares issued   99,710                  
United Kingdom Of England [Member]                      
Income tax rate               19.00%      
CANA Pharmaceutical Laboratories, S.A. ("Cana") [Member]                      
Cash               $ 873,600      
Issuable stock amount               $ 138,667      
Shares issued               46,377      
Secured Promissory Note         $ 4,457,520            
Asset acquision         $ 5,469,787            
Zip Doctor Inc [Member]                      
Payment in fees       $ 8,788              
Cash       150,000              
Intangible assets       $ 158,788